| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.009 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.12 | 0.01 |